JPRN-UMIN000001609已完成未知
PK/PD analysis of methotrexate in the rheumatic treatment made use of genetic polymorphism of drug delivery protein and clinical development - PK/PD analysis of methotrexate in the rheumatic treatment and clinical development
Oita University Hospital Clinical pharmacology center0 个研究点目标入组 300 人开始时间: 2008年12月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.History of severe circulatory disease, hepatic disorder,renal disease, digestive system disease, blood disorder, interstitial pneumonia. 2.The patient which treatment of RA is no good. 3.The patient having therapeutic experience of surgical remedy for RA during study participation. 4.A pregnant woman, nursing mother, a person who hope for the pregnancy all over the study period.
研究者
相似试验
进行中（未招募）
1 期
A randomized placebo-controlled trial to investigate clinical efficacy and safety of methotrexate in erosive inflammatory hand osteoarthritis.orwegian adult males and females with symptomatic erosive inflammatory hand osteoarthritis.MedDRA version: 21.1Level: LLTClassification code 10016686Term: Finger osteoarthritisSystem Organ Class: 100000004859MedDRA version: 21.1Level: LLTClassification code 10019115Term: Hand osteoarthritisSystem Organ Class: 100000004859MedDRA version: 21.0Level: LLTClassification code 10064565Term: Erosive osteoarthritisSystem Organ Class: 100000004859EUCTR2019-004641-33-NODiakonhjemmet Hospital210
进行中（未招募）
1 期
The MERINO trialErosive hand osteoarthritisMedDRA version: 21.1Level: LLTClassification code: 10019115Term: Hand osteoarthritis Class: 10028395CTIS2023-510523-30-00Diakonhjemmet Sykehus AS153
已完成
4 期
In methotrexate resistant rheumatoid arthritis, switching methotrexate to tofacitinib versus adding tofacitinib to methotrexate, open labeled, multicenter randomized non-inferiority study.Rheumatoid arthritisJPRN-UMIN000017440Graduate School of Medicine and School of Medicine, Chiba University the department of allergy and clinical immunology134
已完成
不适用
Kinetics of Elimination of Methotrexate and Its Major Metabolite 7-OH-methotrexate for Observant PatientsRheumatoid ArthritisNCT03852888CHU de Reims62
已完成
3 期
PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phaseNL-OMON22681Sint Maartenskliniek Nijmegen100